Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm

Journal of Clinical Neuroscience

Volumn 10, Issue 3, 2003, Pages 297-299

  Yapicioǧlu, Hacer ^a   Narli, Nejat ^a   Satar, Mehmet ^a   Soyupak, Süreyya ^a   Altunbasak, Sakir ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Intraventricular streptokinase; Posthaemorrhagic hydrocephalus; Preterm; Ventriculoperitoneal shunt

Indexed keywords

STREPTOKINASE;

ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYDROCEPHALUS; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0038171264     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00028-6     Document Type: Article

References (16)

1. De Viries LS, Larroche JC, Levene MI. Intracranial sequela. In: Levene MI, Bennett MJ, Punt J (eds) Fetal and Neonatal Neurology and Neurosurgery. Churchill Livingstone, Edinburg 1988; 346-352.
2. Hislop J, Dubowitz L, Kaiser A, Singh P, Whitelaw A. Outcome of infants shunted for posthemorrhagic dilatation. Dev Med Child Neurol 1988; 30: 451-456.
3. Ventriculomegaly Trial Group. Randomised trial of early tapping vs conservative management in infants with posthemorrhagic hydrocephalus. Arch Dis Child 1990; 65: 3-10.
4. Whitelaw A, Rivers RPA, Creighton L, Gaffney P. Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus. Arch Dis Child 1992; 67: 12-14.
5. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N. Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhaggic hydrocephalus. Arch Dis Child 1996; 75: F20-F26.
6. Hudgins RJ, Boysdton WR, Hudgins PA, Morris R, Adler SM, Gilreath CL. Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Neurosurgery 1997; 26(6): 281-287.
7. 2 in the newborn infant. Acta Paediatr Scand 1991; 80: 22-27.
8. Whitelaw A, Mowinckel MC, Abildgaard U. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis. Acta Paediatr 1995; 84(8): 933-936.
9. Cupido C, Kirpalani H, Mernagh J. The central nervous system. In: Kirpalani H, Mernagh J, Gill G (eds) Imaging of the Newborn Baby. Churchill Livingstone, Edinburg 87-109.
10. Hill A, Volpe JJ. Normal pressure hydrocephalus in the newborn. Pediatrics 1981; 68: 623-629.
11. Volpe JJ. In: Neurology of the Newborn. Second edn. W.B. Saunders, Philadelphia, PA 1995: 403-463.
12. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 3. Neurosurgery 1986; 19: 553-572.
13. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991; 74(1): 81-86.
14. Hudgins RJ, Boysdston WR, Hudgins PA, Adler SR. Treatment of intraventricular hemorrhage in the premature infant with urokinase. A preliminary report. Pediatr Neurosurg 1994; 20(3): 190-197.
15. Whitelaw A. Intraventricular streptokinase after intraventricular hemorrhage in newborn infant. Cochrane Review, The Cochrane Library, Issue 3, 2000, Oxford Update Software.
16. Luciano R, Velardi F, Romagnoli C, Papacci P, De Stefano V, Tortorolo G. Failure of fibrinolytic endoventricular treatment to prevent neonatal posthaemorrhagic hydrocephalus. A case control trial. Childs Nerv Syst 1997; 13: 73-76.